The slide agglutination test (SAT), microagglutination test (MAT), and card agglutination test (CAT) were compared with each other, using the tube agglutination test (TAT) as the standard method, by two reference laboratories to determine effectiveness as screening tests for human brucellosis. TAT titers of 1,253 sera tested in both laboratories were compared. In one laboratory, 1,270 sera were tested by the TAT and SAT, while the other laboratory tested 1,261 sera by both methods. Of these sera, 1,155 were tested in one laboratory by the CAT and 187 sera were tested by the MAT. Compared with that of the TAT (-160 positive), the sensitivities were 97 to 100% (SAT), 90% (CAT), and 88% (MAT). The specificities were 88 to 89% (SAT), 98% (CAT), and 88% (MAT). For populations with a low prevalence of disease, increased specificity offers higher predictive value, so the CAT and MAT are preferable for screening purposes and the choice between tests depends on the number and frequency of tests performed. Ail sera reactive in the CAT and MAT should be retested with the TAT.
The tube agglutination test (TAT) has become the standard method for serodiagnosis of brucellosis (3, 9) . This test, using the antigen prepared by the National Animal Disease Laboratory (NADL), Ames, Iowa, or a standardized commercial equivalent, is the recognized test for obtaining quantitative information about the immune response to brucellosis. Although the TAT is the standard method, it is labor, reagent, and time intensive and, therefore, not suited as a primary test for laboratories with large specimen workloads. The TAT is not convenient for field use or for conducting serologic surveys in the support of epidemiologic investigations. Several rapid screening tests have been proposed (1-4, 7), but variation in antigens, incubation times, and interpretation of significant reactivity compared with that of the TAT makes it difficult to evaluate their suitability for screening human sera. The more widely accepted screening tests include the slide agglutination test (SAT), card agglutination test (CAT), and microagglutination test (MAT) (1, 4, 7) . These tests may vary widely between laboratories unless they are carefully standardized against the TAT, using the NADL antigen and sera of known reactivity. The general lack of adequate culture results and clinical histories further complicates any attempt to assess the significance of titers or reactivities of the various tests. In this paper, sensitivity and specificity of the SAT, MAT, and CAT were calculated arbitrarily, using results of the TAT to define true-positive and true-negative categories.
The purpose of this study was to assess the utility of the SAT, MAT, or CAT as a screening method for brucellosis. The Hygienic Laboratory (UHL), University of Iowa, Iowa City, receives large numbers of sera from packing plant workers or other individuals with a high risk of occupational exposure, and a simple yet reliable screening test is essential to that laboratory. Both the Centers for Disease Control (CDC), Atlanta, Ga., and the UHL obtained the TAT titers on 1,253 sera. UHL tested 1,270 sera by the TAT and SAT, while CDC tested 1,261 of these sera by TAT we used the procedural methods described in their "Brucellosis Card Test" kit brochure. We dispensed 0.03 ml of serum and 0.03 ml of antigen onto one teardrop test area. Antigen and serum were mixed and spread over the entire area. The cards were rocked by hand for 4 min and read immediately.
MAT. The MAT was performed at the CDC as described by Gaultney et al. (4) .
RESULTS
A total of 1,253 sera were tested by both CDC and UHL, using the TAT. The distribution of titers obtained in both laboratories by the TAT is shown in Table 1 . We found the two laboratories in agreement within ± one dilution on 1,229 of 1,253 (98.1%) sera tested. There is some disagreement about the titer that should be considered significant for the TAT. When only specimens with titers of -80 were considered, the two laboratories were in agreement within ± one dilution on 57 of 64 (89.1%) sera tested. If a titer of .160 were established as a cutoff, CDC would report two sera at <160, and UHL would report five sera at <160. Using a cutoff of .80, CDC would report six sera at <80, and UHL would report ten sera at <80. The four specimens for which UHL found titers of 80 or 160, but CDC found negative, were negative in all other tests. The overall geometric means for specimens yielding a titer of at least 20 were 52.7 and 48.2 for CDC and UHL, respectively.
If a TAT titer of .80 is considered a positive indication of brucellosis (Table 2) , CDC found no false-negative slide tests and UHL found four (7.4%) with that result. CDC found 109 (9.1%) false-positive slide tests compared with 128 (10.5%) from UHL. If a TAT titer of .160 is considered positive for brucellosis (Table 3) , CDC found no false-negative slide tests, while UHL found one (3.4%). CDC found 138 (11.2%) false-positive slide tests compared with 150 (12.1%) found by UHL. A group of 187 sera were tested by both the TAT and the MAT. Of these, 180 were tested by the TAT in both the UHL and CDC laboratories. To determine if the titer differences obtained by comparing the MAT with the TAT were significantly different from those obtained by the two laboratories performing the TAT, we made two comparisons: (i) MAT titers were compared to those of the TAT (both performed by CDC) and (ii) the TAT titers obtained by CDC were compared with those obtained by UHL. The comparison of TAT results of 180 sera tested in both laboratories is presented in Table 4 . The TAT titers from both laboratories were in agreement for 101 (57.7%) of the sera, while 64 (36.6%) differed by one dilution, and 10 (5.7%) differed by two dilutions. The MAT and TAT were performed on 187 sera, including the 180 sera tested by TAT in both laboratories. These results are presented in Table 5 . The MAT and TAT titers were in agreement for 122 (67%) of the sera tested, 46 (25.3%) sera differed by one dilution, 13 (7.1%) differed by two dilutions, and one (<1%) differed by three dilutions. Five sera were insufficient for repeat testing, and the endpoint was not determined. These sera were omitted from the calculations based on data from Tables 4 and 5 . Specimens with titers differing by one, two, or three dilutions occurred in both the lower and higher titer ranges. The TAT tended to give higher titers in the lower dilutions, while the MAT usually gave higher titers in the higher dilutions.
The CAT and TAT were performed on 1,155 sera by CDC. The results are presented in Table 6 . When the TAT titer of .80 was used as a positive test, the sensitivity of the CAT compared with that of the TAT was 65.5% and the specificity was 99.3%. When a TAT titer of .160 was considered significant, only three false-negative card test results occurred. Compared with those of the TAT, the sensitivity of the CAT was 90.0% and the specificity was 98.3%. 
DISCUSSION
Any attempt to assess the usefulness of a screening test for brucellosis is complicated for two reasons: only one of the sera included in the study came from patients with cultureproven brucellosis, and no consensus among investigators exists as to what titer reflects a positive specimen. UHL considers a titer of .80 significant when the TAT is incubated at 37°C for 24 h, but CDC considers a titer of -160 significant for the TAT incubated at 37°C for 48 h. Since we cannot report unequivocally which specimens are "positive," we compared titers derived from the various tests. Although it was impossible to select a cutoff value from these findings, it was encouraging that the two laboratories maintained such a high agreement when using the standardized test and antigen.
Sackett (8) gave definitions for epidemiologic surveys, screening, case finding, and diagnosis that were the basis for assigning varying degrees of importance to certain properties of tests used for different purposes. For a test used for screening purposes, acceptability and sensitivity were of crucial importance; simplicity, cost, precision, accuracy, specificity, and predictive value were moderately important. For a test used for diagnostic purposes, precision, accuracy, specificity, and predictive value were of crucial importance, sensitivity was of major importance, and simplicity, acceptability, and cost were irrelevant.
The SAT, CAT, and MAT have acceptability, which was defined by Sackett (8) as a property that leads to good cooperation. When compared to that of the TAT (-160 positive), the sensitivities of the three tests were as follows: SAT, 97 to 100%; CAT, 90%; MAT, 88%. The specificities were as follows: SAT, 88 to 89%; CAT, 98%; MAT, 98%. Vecchio (10) stated that if the prevalence of a disease in a population is low (for example, 2%), the maximal predictive value of a positive test is 66.9% even when both sensitivity and specificity of the test are 99%. He stated that the specificity of a test should be increased even at a cost of decreased sensitivity when the prevalence of a disease is low. On this basis the CAT and MAT are preferable to the SAT for screening purposes except that the MAT lacks the simplicity of the others.
The incidence of brucellosis in the United States is 150 to The interlaboratory reproducibility of TAT titers between CDC and UHL for sera selected for the MAT study was very good. The geometric mean titer was not significantly different between the MAT and TAT. The MAT usually gives a higher titer than the TAT at high antibody levels and is in close agreement at low antibody levels (2, 4) .
A screening test is needed by only a few laboratories, such as UHL, that service areas in which the prevalence of brucellosis is job related. UHL tests specimens from nonsymptomatic individuals at the time they are hired at several meat-packing plants to establish their brucellosis antibody status. For such laboratories with trained personnel, our findings support the recommendations of Brown et al. (2) that the MAT is a useful screening test, requires little time and reagent, and provides fast results.
In comparing the CAT with the TAT, Russell et al. (7) evaluated 1,701 sera and reported a sensitivity of 95.3% and a specificity of 84.1% when a positive TAT was considered to be .160. These investigators found that the CAT resulted in a high number of false-positives and, therefore, was an unacceptable diagnostic test even in a high-risk population such as abattoir workers. However, they failed to discuss the high number of diagnostic false-positives the TAT would also give among this group. Buchanan et al. (3) found that 39 of 91 (42.9%) nonsymptomatic abattoir workers had TAT titers of .160. They examined the use of the CAT for diagnosis in a way that meets the definition of diagnosis given by Sackett (8) in that persons tested were ill and actively sought the services of a physician to determine the cause of illness. They found no false-positive card tests in ill patients and considered the positive CAT of value in the diagnosis of symptomatic patients. In our study, when a TAT titer of <160 was called negative, we found 19 falsepositive reactions by the CAT. Only two of these specimens were completely negative by the TAT, 11 had TAT titers of 80, and 6 
